GenTarget, USA  

Founded in 2008 in the USA, GenTarget develops and supplies proprietary biological reagents and services centered on viral particle–based gene delivery technologies. The company provides ready-to-use lentiviral, AAV, and adenoviral vectors, as well as pre-established mammalian stable cell lines designed for gene overexpression, gene silencing, and miRNA expression applications in biomedical research.